Abnormalities of both insulin secretion and insulin action occur in NIDDM. It is not clear, however, which is the primary defect. Recently, it has been suggested that the frequency of insulin pulses is an important factor regulating insulin action in normal humans. We examined the relationship between pulsatile insulin secretion and insulin action in eight NIDDM subjects and eight healthy matched control subjects. Insulin action was assessed at prevailing fasting glucose levels before and after hyperinsulinemia (2-h insulin infusion at 2.0 mU • kg" 1 • min" 1 ). Pulsatility of insulin was assessed by sampling every 2 min for 90 min after an overnight fast and identifying insulin pulses using the computer program Pulsar. Fasting plasma glucose and postabsorptive endogenous glucose production were both greater in diabetic subjects compared with control subjects (10.1 ± 1.2 vs. 5.4 ± 0.1 mmol/1, P < 0.01; 11.8 ± 0.8 vs. 9.9 ± 0.4 junolkg" 1 • min" 1 , P < 0.05). During the 2.0 mU insulin infusion, glucose clearance was lower in the diabetic subjects (3.6 ± 0.7 vs. 6.9 ± 0.5 ml-kg" 1 • min" 1 , P < 0.05), whereas endogenous glucose production was suppressed to a similar degree in both groups (4.5 ± 0.8 vs. 3.6 ± 0.7 (jimol • kg" 1 • min" 1 , NS). The frequency of insulin pulses and glucose clearance were negatively correlated in both diabetic subjects (r = -0.75, P < 0.05) and normal control subjects (r = -0.82, P < 0.01). This negative correlation was also present in both groups taken together (r = -0.72, P < 0.001). There was no correlation between insulin pulse frequency and endogenous glucose production either in the fasting state or during hyperinsulinemia. We concluded that the frequency of insulin pulses and peripheral insulin sensitivity are closely linked in NIDDM and normal subjects. Diabetes 45:683-686, 1996
I
nsulin is secreted in a pulsatile manner, with both long-term ultradian pulses that occur every 80-150 min (1) and also shorter term high-frequency pulses that occur every 8-15 min (2,3). Short-term insulin pulses in normal subjects occur regularly and are preceded by glucose oscillations (3) . In patients with NIDDM, insulin pulses are more frequent and irregular (4) . Abnormal pulsatile secretion of insulin has also been shown in first-degree relatives of patients with NIDDM who have mild fasting hyperglycemia (5) . Because this group is at high risk of developing diabetes, abnormal oscillatory insulin secretion may represent an early abnormality in the development of NIDDM.
Insulin resistance and abnormalities of insulin secretion are both features of established NIDDM. Controversy remains, however, regarding which defect occurs first and is more important in the pathogenesis of NIDDM (6) . Recently, it has been shown that the frequency of insulin pulses is inversely correlated with insulin sensitivity in healthy young nonobese men, which led to the suggestion that the frequency of short-term insulin pulses may play a role in inducing insulin resistance (7) .
The aim of this study was to examine the relationship between insulin pulse frequency and insulin action in patients with established NIDDM and age-matched nondiabetic subjects.
RESEARCH DESIGN AND METHODS
Subjects. Eight NIDDM patients and eight age-, sex-, and weightmatched subjects with no family history of diabetes were recruited (Table 1) . Patients were excluded who were > 125% of ideal body weight (Metropolitan Life Insurance Tables 1955) or had hypertension or any significant cardiac, hepatic, or renal disease.
In diabetic patients, oral hypoglycemic agents were stopped for 2 weeks before assessment of insulin secretion, and therapy was withheld until after assessment of insulin action ~1 week later. All subjects gave written informed consent, and the protocol was approved by the Ethics Committee of the Queen's University of Belfast. Assessment of insulin pulsatility. Patients were admitted to the Metabolic Unit at 8:30 A.M. after a 12-h overnight fast. A cannula (21 gauge; Venflon Viggo, Helsingborg, Sweden) was inserted retrogradely into a dorsal hand vein, and the hand was placed in a temperaturecontrolled Plexiglas box (Northern Ireland Technology Centre, Automation Division, Queen's University of Belfast) maintained at 55°C to allow intermittent sampling of arterialized venous blood. After a basal period of 1 h, blood was withdrawn every 2 min for 90 min for determination of insulin concentrations. Serum insulin concentration was measured by enzyme-linked immunosorbent assay (Abbot IMx, Abbott Laboratories). This assay does not cross-react with proinsulin or split products. The intra-assay coefficient of variation (CV) in our lab during the study was 2.5% at a mean insulin concentration of 5.2 mU/1. The frequencies and amplitudes of the short-term insulin oscillatory peaks were determined using the computer program Pulsar. This program has previously been used to detect pulsatile secretion of insulin and a number of other hormones (7) (8) (9) . Pulses are identified by height and duration from a smoothed baseline using the assay CV as a scale factor. Assessment of insulin action. Insulin action was assessed using the hyperinsulinemic glucose clamp technique. Patients were admitted at 7:45 A.M. on the morning of the study after a 12-h overnight fast. An antecubital vein was cannulated (18 gauge; Venflon Viggo) and used for all infusions. Arterialized blood was obtained from a dorsal hand vein on the opposite side, as described above.
A primed continuous infusion of high-performance liquid chromatography-purified [3- Data are means ± SE or n.
was given during a 2-h equilibration period (-120 min to time 0). The priming dose of H]glucose was adjusted according to the fasting plasma glucose (10) . After the equilibration period, a 2-h continuous infusion of insulin (Humulin S; Lilly, Basingstoke, U.K.) was begun at 2 mU-kg" 1 -min" 1 . Plasma glucose was maintained at the fasting concentration by an exogenous glucose infusion (20%). Exogenous glucose was prelabeled with H]glucose to match the predicted basal plasma glucose specific activity as described previously (10, 11) , with the modification that the primed continuous tracer infusion was reduced to 50% of the basal rate after 20 min and to 25% after 40 min (in order to maintain tracer steady state) and was maintained at this rate throughout the remainder of the hyperinsulinemic period. Analytical techniques. Arterialized venous blood was used for all analyses. Plasma for measurement of glucose specific activity was deproteinized with barium hydroxide and zinc sulfate. After centrifugation, the supernatant was counted in a liquid-scintillation spectrometer (Tn-Carb 2000 CA; Canberra Packard, Pangbourne, U.K.). Aliquots of tracer infusate and labeled exogenous glucose infusion were spiked into nonradioactive plasma and processed in parallel with plasma samples to allow calculation of H]glucose infusion rates. Calculations. The non-steady-state equations of Steele et al. (12) , as modified by De Bodo et al. (13) , were used to determine rates of glucose appearance and disappearance during the periods -30 min to time 0 and 90-120 min, assuming a pool fraction value of 0.65 and an extracellular volume of 190 ml/kg. Infusion rates of H]glucose were calculated as the sums of the tracer infused continuously and the tracer in the labeled exogenous glucose infusion. Rates of endogenous (hepatic) glucose production were then calculated by subtraction of the exogenous glucose infusion rates required to maintain euglycemia from the isotopically determined rates of glucose appearance. Glucose clearance was calculated by dividing the rate of glucose utilization by the prevailing plasma glucose concentration (14) . The insulin sensitivity index (ISI) was calculated using the formula 
RESULTS
Fasting glucose and insulin concentrations were both higher in diabetic than in control subjects. Diabetic and control subjects were clamped at their fasting levels (CV 4.4 ± 0.4%).
The results of the glucose clamp studies are summarized in Table 2 . Insulin infusion led to comparable steady-state insulin levels in both groups. Glucose clearance and the ISI were higher in the control subjects than in NIDDM subjects, confirming the presence of peripheral insulin resistance in the diabetic subjects. The plasma H] glucose specific activity was maintained constant throughout (CV -3 0 to 120 min 6 ± 2%). Postabsorptive endogenous glucose production was 19% greater in the diabetic subjects. There was no correlation between fasting glucose and endogenous glucose production in either the diabetic patients or control subjects. Endogenous glucose production was suppressed to a similar extent in both groups during the 2.0 mU • kg" 1 • min" 1 insulin infusion.
The results of insulin pulse analysis are shown in Table 3 . The number of insulin pulses tended to be greater in the diabetic subjects, although the difference was not statistically significant. Mean pulse amplitude and area were similar in the two groups. As shown in Fig. 1 , a significant negative correlation was found between the number of insulin pulses and glucose clearance in both the diabetic subjects (r = -0.75, P < 0.05) and the normal subjects (r = -0.82, P < 0.01) and also in both groups taken together (r = -0.72, P < 0.001). A similar trend was also present in the correlation between the number of insulin pulses and the ISI in diabetic (r = -0.65, P = 0.08) and control (r = -0.79, P < 0.05) subjects and in both groups taken together (r = -0.71, P < 0.01). There was no association between pulse amplitude or pulse area and glucose clearance. The frequency of insulin pulses was not related to postabsorptive endogenous glucose production or to the degree of suppression of endogenous glucose production during hyperinsulinemia. There was no correlation between fasting plasma glucose and insulin pulse frequency in NIDDM subjects.
DISCUSSION
Our results demonstrated a novel association between insulin pulse frequency and glucose clearance in NIDDM subjects and confirmed the association previously shown in a younger group of nonobese subjects (7). There was no relationship between insulin pulse frequency and endogenous glucose production in the fasting state or the degree of suppression during hyperinsulinemia.
Insulin pulse characterization requires a technique that differentiates true small-amplitude insulin oscillations from random fluctuations in insulin levels due to measurement error (16) . In this study, experimental error was reduced by using a highly sensitive insulin assay. Insulin pulses were identified using the computer program Pulsar, which uses the assay CV as a scale factor. Unlike autocorrelation and spectral analysis, this program does not rely on identification of a regular pulse rhythm, which is important in this study because it examines insulin pulses in NIDDM.
In patients with NIDDM, insulin pulses are more frequent and irregular than those in normal control subjects (4) . First-degree relatives of patients with NIDDM also lack regular pulsatile insulin secretion, suggesting that this abnormality occurs early in those predisposed to diabetes (5). In our study, there was a tendency for an increase in pulse frequency in NIDDM subjects. However, this did not reach statistical significance, which may be related to the smaller number of subjects studied.
Oscillatory insulin secretion has been shown to be initiated in the pancreas (17, 18) . It has been proposed that pulsatile insulin exposure regulates insulin receptor function (19, 20) . Pulsed insulin delivery compared with continuous insulin delivery has a greater hypoglycemic effect in association with increased monocyte insulin receptor binding in both normal and diabetic subjects (19, 20) . It has also been shown that pulsatile insulin administration produces a greater inhibition of hepatic glucose production than the continuous delivery of the same amount of insulin and that this differential effect diminishes as pulse frequency varies from the rate reported for spontaneous oscillations in normal subjects (21) . Our results showed a relationship between the frequency of insulin pulses and peripheral but not hepatic insulin sensitivity. To explain these observations, we hypothesized that basal insulin pulses at increased frequency alter peripheral receptor sensitivity when subsequently challenged by clamp levels of hyperinsulinemia. It is perhaps surprising that liver insulin sensitivity is not similarly affected, since fenestrated liver sinusoids allow rapid insulin transit and the facility for liver cells to "see" altered pulse frequency (22) .
Because glucose utilization varies with plasma glucose concentration, the metabolic clearance rate of glucose was used to allow comparison of patients at different prevailing plasma glucose concentrations. We also chose patients with only moderate hyperglycemia because at higher levels saturation of the glucose-uptake mechanism occurs, so glucose clearance is no longer independent of glucose level (23) . Similar results were also obtained using the ISI, which is independent of the level of glycemia and insulinemia at which the clamps are performed (15) .
The results also demonstrate the presence of both peripheral and hepatic insulin resistance in NIDDM. The finding that fasting endogenous glucose production was 19% greater in diabetic subjects than in control subjects is consistent with recent observations (24) . Previous studies using tritiated glucose that had shown more markedly elevated endogenous glucose production in NIDDM in proportion to the degree of fasting hyperglycemia used fixed priming, i.e., the ratio between priming dose and constant H] glucose infusion rate was constant (25) . Adjusting the priming dose to take account of fasting hyperglycemia allows more rapid attainment of isotope steady state and avoids this overestimation (13) .
Abnormalities of both insulin secretion and insulin action are frequently observed in NIDDM. Our study has suggested that abnormalities of insulin secretion and insulin action are very closely linked. Many previous studies have been conducted to try to detect which defect occurs earliest in the pathogenesis of NIDDM and therefore has greater etiological importance. Our results, however, suggested that this approach may prove futile. The nature of the association between insulin pulse frequency and insulin resistance may be that frequent asynchronous exposure of insulin receptors induces receptor and postreceptor defects.
